Zhaoling Dan

Title: **Zhaoling Dan: A Pioneer in PI3K Inhibitor Development**

Introduction

Zhaoling Dan, based in Shanghai, China, is a notable inventor recognized for his significant contributions to the field of pharmaceuticals. With a focus on developing innovative PI3K inhibitors, Dan has made strides in the treatment of various diseases through his pioneering research and patented inventions.

Latest Patents

Zhaoling Dan holds a patent titled "PI3K inhibitor, and pharmaceutically acceptable salt, polycrystalline form, and application thereof." This invention centers around a specific polycrystalline form of 4-chloro-5-(6-(1-(methylsulfonyl)cyclopropyl)-2-morpholinopyrimidin-4-yl)pyridin-2-amine, including its pharmaceutically acceptable salt. The patent also details a pharmaceutical composition that incorporates this inhibitor and outlines potential applications for the compound in medical settings.

Career Highlights

Throughout his career, Zhaoling Dan has collaborated with various pharmaceutical companies, impacting the industry through his work. He has been associated with Shanghai Haiyan Pharmaceutical Technology Co., Ltd. and Yangtze River Pharmaceutical Group Co., Ltd., where he has played a crucial role in advancing pharmaceutical research and development.

Collaborations

Dan has worked alongside talented professionals in the industry, including his coworkers Taotao Jiang and Qiang Xu. Their collaborative efforts have contributed to the successful development and realization of his innovative ideas in pharmaceutical technology.

Conclusion

Zhaoling Dan's contributions to the field of pharmaceuticals, particularly through his patented PI3K inhibitor, highlight his role as an influential inventor. His work continues to inspire innovations in the treatment of diseases, showcasing the importance of dedicated research and collaborative spirit in advancing healthcare solutions.